ArticleBMC health services research2010
Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: a case study in Zambia.
Article in BMC health services research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 31 citations in OpenAlex.
- Factors that influence the provision of intrapartum and postnatal care by skilled birth attendants in low- and middle-income countries: a qualitative evidence synthesis.The Cochrane database of systematic reviews · 2017Pooled it
- Access barriers to obstetric care at health facilities in sub-Saharan Africa-a systematic review.Systematic reviews · 2017Pooled it
- Why are women dying when they reach hospital on time? A systematic review of the 'third delay'.PloS one · 2013Pooled it
- Quality of maternal and child health services in Tanzanian primary healthcare: a 2021-2022 star rating review.Reproductive health · 2025Article
- Community engagement to develop a dialogue-drama on adolescent pregnancy in a marginalised migrant population on the Thailand-Myanmar border: an ethnographic approach to participatory action research.Global health action · 2024Article
- Factors affecting use of magnesium sulphate for pre-eclampsia or eclampsia: a qualitative evidence synthesis.BJOG : an international journal of obstetrics and gynaecology · 2022Review
- Access to sexual and reproductive health commodities in East and Southern Africa: a cross-country comparison of availability, affordability and stock-outs in Kenya, Tanzania, Uganda and Zambia.BMC public health · 2020Article
- Perception of Midwives Towards Magnesium Sulfate Use at Chatinkha Maternity Wing in Blantyre, Malawi: A Qualitative Study.International journal of women's health · 2020Article
- Screening and management of pre-eclampsia and eclampsia in antenatal and labor and delivery services: findings from cross-sectional observation studies in six sub-Saharan African countries.BMC pregnancy and childbirth · 2018Observational
- Use of magnesium sulfate before 32 weeks of gestation: a European population-based cohort study.BMJ open · 2017Article
- Health care provider knowledge and routine management of pre-eclampsia in Pakistan.Reproductive health · 2016Article
- Situational analysis of facilitators and barriers to availability and utilization of magnesium sulfate for eclampsia and severe preeclampsia in the public health system in Brazil.BMC pregnancy and childbirth · 2016Article
- Barriers and facilitators to the quality use of essential medicines for maternal health in low-resource countries: An Ishikawa framework.Journal of global health · 2015Article
- Availability, prices and affordability of essential medicines in Haiti.Journal of global health · 2013Article
- Prevention and management of severe pre-eclampsia/eclampsia in Afghanistan.BMC pregnancy and childbirth · 2013Article
- Maternal and fetal outcomes after introduction of magnesium sulphate for treatment of preeclampsia and eclampsia in selected secondary facilities: a low-cost intervention.Maternal and child health journal · 2013Article
- An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management.BMC pregnancy and childbirth · 2013Review
- Article
- Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala.Globalization and health · 2012Article
- Priority medicines for maternal and child health: a global survey of national essential medicines lists.PloS one · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPre-eclampsia and eclampsia are serious complications of pregnancy and major causes of maternal mortality and morbidity worldwide. According to systematic reviews and WHO guidelines magnesium sulphate injection (MgSO4) should be the first -line treatment for severe pre-eclampsia and eclampsia. Studies have shown that this safe and effective medicine is unavailable and underutilized in many resource poor countries. The objective of this study was to identify barriers to the availability and use of MgSO4 in the Zambian Public Health System.
methodsA 'fishbone' (Ishikawa) diagram listing probable facilitators to the availability and use of MgSO4 identified from the literature was used to develop an assessment tool. Barriers to availability and use of MgSO4 were assessed at the regulatory/government, supply, procurement, distribution, health facility and health professional levels. The assessment was completed during August 2008 using archival data, and observations at a pragmatic sample of health facilities providing obstetric services in Lusaka District, Zambia.
resultsThe major barrier to the availability of MgSO4 within the public health system in Zambia was lack of procurement by the Ministry of Health. Other barriers identified included a lack of demand by health professionals at the health centre level and a lack of in-service training in the use of MgSO4. Where there was demand by obstetricians, magnesium sulphate injection was being procured from the private sector by the hospital pharmacy despite not being registered and licensed for use for the treatment of severe pre-eclampsia and eclampsia by the national Pharmaceutical Regulatory Authority.
conclusionsThe case study in Zambia highlights the complexities that underlie making essential medicines available and used appropriately. The fishbone diagram is a useful theoretical framework for illustrating the complexity of translating research findings into clinical practice. A better understanding of the supply system and of the pattern of demand for MgSO4 in Zambia should enable policy makers and stakeholders to develop and implement appropriate interventions to improve the availability and use of MgSO4.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.